Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

NP105-113-B*07:02-specific CD8+ T cell responses are considered among the most dominant in SARS-CoV-2-infected individuals. We found strong association of this response with mild disease. Analysis of NP105-113-B*07:02-specific T cell clones and single-cell sequencing were performed concurrently, with functional avidity and antiviral efficacy assessed using an in vitro SARS-CoV-2 infection system, and were correlated with T cell receptor usage, transcriptome signature and disease severity (acute n = 77, convalescent n = 52). We demonstrated a beneficial association of NP105-113-B*07:02-specific T cells in COVID-19 disease progression, linked with expansion of T cell precursors, high functional avidity and antiviral effector function. Broad immune memory pools were narrowed postinfection but NP105-113-B*07:02-specific T cells were maintained 6 months after infection with preserved antiviral efficacy to the SARS-CoV-2 Victoria strain, as well as Alpha, Beta, Gamma and Delta variants. Our data show that NP105-113-B*07:02-specific T cell responses associate with mild disease and high antiviral efficacy, pointing to inclusion for future vaccine design.

Original publication

DOI

10.1038/s41590-021-01084-z

Type

Journal article

Journal

Nat Immunol

Publication Date

01/2022

Volume

23

Pages

50 - 61

Keywords

Aged, Amino Acid Sequence, Antibodies, Viral, Antibody Affinity, COVID-19, Cell Line, Transformed, Female, Gene Expression Profiling, HLA-B7 Antigen, Humans, Immunodominant Epitopes, Immunologic Memory, Male, Middle Aged, Nucleocapsid Proteins, Receptors, Antigen, T-Cell, SARS-CoV-2, Severity of Illness Index, T-Lymphocytes, Cytotoxic, Vaccinia virus